The authors suggest neuroinflammation warrants consideration of immunomodulatory therapies but provide no evidence for therapeutic efficacy. This represents a critical translational gap for disease modification strategies. Gap type: open_question Source paper: In vivo PET imaging of neuroinflammation in familial frontotemporal dementia. (2021, Journal of neurology, neurosurgery, and psychiatry, PMID:33122395)
Landscape Summary: Can immunomodulatory therapies effectively target neuroinflammation in familial FTD? is a 0.79 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
Can immunomodulatory therapies effectively target neuroinflammation in familial FTD? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: